Morepen Laboratories Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Morepen secures Loratadine approval for export to China".
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has received regulatory approval to export Loratadine, an antihistamine medication commonly used for allergy relief, to the Chinese market. Loratadine is a well-established generic drug that would be manufactured and supplied by Morepen. The approval enables the company to tap into China's large pharmaceutical market. This adds a new geography to Morepen's export portfolio. No financial figures or order value have been disclosed in this announcement.
Positive signal for the company as it opens access to the world's second-largest pharmaceutical market, potentially boosting export revenues in the medium term. However, short-term stock impact may be limited since no deal size or volume commitments have been disclosed yet.